Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel S Pratt

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Current Opinion in Gastroenterology|April 28, 2009
Hepatitis B: significant advances and unmet challengesDaniel S Pratt
Current Opinion in Gastroenterology|April 15, 2008
Liver disordersDaniel S Pratt
Hepatology (Baltimore, Md.)|January 24, 2019
The Role of Bezafibrate, a Peroxisome Proliferator-Activated Receptor Alpha Agonist, in Patients With Primary Biliary CholangitisDaniel S Pratt
Current Opinion in Gastroenterology|April 9, 2005
Cholestasis and cholestatic syndromesDaniel S Pratt
The New England Journal of Medicine|August 18, 2016
Primary Biliary Cholangitis--A New Name and a New TreatmentDaniel S Pratt
Hepatology International|March 20, 2015
Time to update radiological criteria for non-invasive diagnosis of hepatocellular carcinomaSanjay Saini, Daniel S Pratt
Journal of Clinical Gastroenterology|January 23, 2008
Cholangiocarcinoma: natural history, treatment, and strategies for surveillance in high-risk patientsPatrick Yachimski, Daniel S Pratt
Therapeutic Advances in Gastroenterology|December 25, 2010
Current status of therapy for hepatocellular carcinomaKathleen E Corey, Daniel S Pratt
Journal of Clinical Gastroenterology|January 25, 2003
Klebsiella liver abscessDavid J Kim, Daniel S Pratt
Current Opinion in Gastroenterology|March 22, 2006
Cholestasis and cholestatic syndromesAnna E Rutherford, Daniel S Pratt
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Current Opinion in Gastroenterology|April 28, 2009
Hepatitis B: significant advances and unmet challengesDaniel S Pratt
Current Opinion in Gastroenterology|April 15, 2008
Liver disordersDaniel S Pratt
Hepatology (Baltimore, Md.)|January 24, 2019
The Role of Bezafibrate, a Peroxisome Proliferator-Activated Receptor Alpha Agonist, in Patients With Primary Biliary CholangitisDaniel S Pratt
Current Opinion in Gastroenterology|April 9, 2005
Cholestasis and cholestatic syndromesDaniel S Pratt
The New England Journal of Medicine|August 18, 2016
Primary Biliary Cholangitis--A New Name and a New TreatmentDaniel S Pratt
Hepatology International|March 20, 2015
Time to update radiological criteria for non-invasive diagnosis of hepatocellular carcinomaSanjay Saini, Daniel S Pratt
Journal of Clinical Gastroenterology|January 23, 2008
Cholangiocarcinoma: natural history, treatment, and strategies for surveillance in high-risk patientsPatrick Yachimski, Daniel S Pratt
Therapeutic Advances in Gastroenterology|December 25, 2010
Current status of therapy for hepatocellular carcinomaKathleen E Corey, Daniel S Pratt
Journal of Clinical Gastroenterology|January 25, 2003
Klebsiella liver abscessDavid J Kim, Daniel S Pratt
Current Opinion in Gastroenterology|March 22, 2006
Cholestasis and cholestatic syndromesAnna E Rutherford, Daniel S Pratt
Pageof 5